FlexStent, LLC has sued Abbott Laboratories, Corp; Abbot Vascular, Inc.; Abbot Cardiovascular Systems, Inc.; and Abbot Vascular Solutions, Inc. in the Central District of California for infringement of U.S. Patent No. 6,187,035 (“Vascular stent”).  FlexStent accuses Abbott’s “Xience” line of drug-eluting stents of infringement.

The Court denied Cochlear’s motion for judgment as a matter of law as to non-infringement. The Court denied Cochlear’s motion for a new trial on damages.  The Court granted Alfred E. Mann Foundation’s motions for supplemental damages and enhanced damages.  The Court then doubled the damages.

Best Medical Int’l, Inc. has sued Varian Medical Systems, Inc. and Varian Medical Systems Int’l AG (collectively “Varian”) for infringement of U.S. Patent Nos. 6,038,283 (“Planning method and apparatus for radiation dosimetry”); 6,393,096 (“Planning method and apparatus for radiation dosimetry”); 7,015,490 (“Method and appartus for optimization of collimator angles in intensity modulated radiation therapy treatment”); and 7,266,175 (“Planning method for radiation therapy”) in the District of Delaware.  Best Medical accuses Varian’s Clinac® linear accelerator, Clinac® iX linear accelerator System, VitalBeam® Radiotherapy System, Trilogy® System, TrueBeam® Radiotherapy System, and Halcyon™ Radiotherapy System, in conjunction with at least Varian’s Eclipse™ Treatment Planning System and/or RapidPlan™ Knowledge-Based Planning System and/or Varian’s RapidArc® Planning System of infringement.